KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Shares Repurchased (2016 - 2025)

Eli Lilly's Shares Repurchased history spans 14 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 26.59% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $4.1 billion, up 64.32%, while the annual FY2025 figure was $4.1 billion, 64.32% up from the prior year.
  • Shares Repurchased reached $1.5 billion in Q4 2025 per LLY's latest filing, up from $708.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $2.1 billion in Q4 2024 to a low of $446.1 million in Q3 2024.
  • Average Shares Repurchased over 5 years is $1.0 billion, with a median of $750.0 million recorded in 2021.
  • Peak YoY movement for Shares Repurchased: tumbled 50.0% in 2023, then skyrocketed 58.73% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $750.0 million in 2021, then skyrocketed by 100.0% to $1.5 billion in 2022, then crashed by 50.0% to $750.0 million in 2023, then soared by 173.85% to $2.1 billion in 2024, then decreased by 26.59% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Shares Repurchased are $1.5 billion (Q4 2025), $708.1 million (Q3 2025), and $692.2 million (Q2 2025).